ClinicalTrials.Veeva

Menu

Effect of Vitamin B12 on the Development of Sepsis, in Culture Positive Patients (Vit B12)

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Completed

Conditions

Bacteremia

Study type

Observational

Funder types

Other

Identifiers

NCT04008446
2019-00702

Details and patient eligibility

About

This is an prospective observational study assessing the effect of vitamin B12 on the odds of developing sepsis in patients with infection confirmed by a positive culture result.

The hypothesis is that patients with infection confirmed by positive cultures who develop sepsis have lower vitamin B12 levels than patients infection, confirmed by positive cultures, who do not develop sepsis.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults (≥18 years old)
  • Infection, confirmed by a positive culture result
  • Signed informed consent.

Exclusion criteria

  • Pregnancy and/or breast feeding
  • Inability to follow the procedures of the study, due to language problems, psychological disorders, social conditions or dementia

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems